Deferasirox Dispersible Tablets 400 Mg
| Product Name | Deferasirox Dispersible Tablets |
| Strength | 400 mg |
| Active Ingredient | Deferasirox |
| Dosage Form | Dispersible Tablet |
| Drug Class | Iron Chelating Agent |
| Indication | Chronic Iron Overload |
| Route of Administration | Oral (Dispersed in liquid) |
| Packaging | Strip /Blister Pack |
Deferasirox Dispersible Tablets 400 Mg
Deferasirox Dispersible Tablets 400 mg are used to treat chronic iron overload in patients who receive frequent blood transfusions. This condition is commonly seen in individuals with disorders such as thalassemia, sickle cell disease, or other types of chronic anemia. Deferasirox belongs to a class of medicines called iron chelators, which help remove excess iron from the body.
The medication works by binding to excess iron in the bloodstream and allowing it to be excreted mainly through feces. By reducing iron accumulation in vital organs such as the liver, heart, and endocrine glands, Deferasirox helps prevent long-term complications related to iron toxicity.
Deferasirox 400 mg dispersible tablets are designed to be dissolved in water or juice before administration, making them easier to consume for patients who have difficulty swallowing conventional tablets. Regular monitoring of iron levels and organ function is recommended during treatment to ensure safe and effective therapy.
Product Features
- Contains deferasirox 400 mg as the active ingredient.
- An effective iron chelating agent used for chronic iron overload.
- Commonly prescribed for patients receiving frequent blood transfusions.
- Dispersible tablet formulation for easy administration.
- Helps reduce iron accumulation in vital organs.
- Suitable for long-term treatment under medical supervision.
How It Helps
- Removes excess iron from the body.
- Prevents damage to organs such as the liver and heart.
- Helps manage iron overload caused by repeated blood transfusions.
- Improves long-term health outcomes in patients with chronic anemia.
- Supports safe iron level management during transfusion therapy.

Reviews
There are no reviews yet.